| human | Q5 |
| P106 | occupation | researcher | Q1650915 |
| Q34231154 | 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventi |
| Q37953801 | 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiogr |
| Q61667402 | 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: Executive Summary |
| Q37953885 | 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventi |
| Q26779649 | 2015 ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial Infarction: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention and the 2013 ACCF/AHA ... |
| Q34498935 | 2015 ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial Infarction: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention and the 2013 ACCF/AHA Guideline |
| Q51219587 | A prospective registry to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions using the "crush technique". |
| Q51793900 | Acute and long-term outcomes of cutting balloon angioplasty followed by gamma brachytherapy for in-stent restenosis. |
| Q77439600 | Acute angiographic and clinical results of the NIR w/SOX stent |
| Q81514556 | Assessing intermediate left main coronary lesions using intravascular ultrasound |
| Q46648595 | Bifurcation coronary lesions treated with the "crush" technique: an intravascular ultrasound analysis |
| Q46834205 | Clinical outcomes after heterogeneous overlap stenting with drug-eluting stents and bare-metal stents for de novo coronary artery narrowings |
| Q36351313 | Comparative effectiveness of revascularization strategies |
| Q51837478 | Comparison of in-hospital and one-year outcomes after multiple coronary arterial stenting in patients > or =80 years old versus those <80 years old. |
| Q73246222 | Comparison of outcomes in men versus women having percutaneous coronary interventions in small coronary arteries |
| Q51638776 | Comparison of safety and efficacy between first and second generation of angio-seal closure devices in interventional patients. |
| Q45839848 | Consideration of a new definition of clinically relevant myocardial infarction after coronary revascularization: an expert consensus document from the Society for Cardiovascular Angiography and Interventions (SCAI). |
| Q45201786 | Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables |
| Q44781955 | Contribution of stent underexpansion to recurrence after sirolimus-eluting stent implantation for in-stent restenosis |
| Q73668666 | Correlation of coronary arterial remodeling determined by intravascular ultrasound with angiographic diameter reduction of 20% to 60% |
| Q45238081 | Creatine kinase-MB enzyme elevation and long-term clinical events after successful coronary stenting in lesions with ruptured plaque |
| Q42167544 | Dominant contribution of negative remodeling to development of significant coronary bifurcation narrowing |
| Q74485871 | Effect of catheter-based iridium-192 gamma brachytherapy on the added risk of restenosis from diabetes mellitus after intervention for in-stent restenosis (subanalysis of the GAMMA I Randomized Trial) |
| Q46711890 | Effectiveness of drug-eluting stent implantation for patients with unprotected left main coronary artery stenosis |
| Q31151437 | Executive Summary: Trends in U.S. Cardiovascular Care: 2016 Report From 4 ACC National Cardiovascular Data Registries |
| Q51329510 | Impact of coronary culprit lesion calcium in patients undergoing paclitaxel-eluting stent implantation (a TAXUS-IV sub study). |
| Q43522240 | Impact of sirolimus-eluting stents on outcome in diabetic patients: a SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudy |
| Q75351724 | Impact of symptomatic peripheral arterial disease on 1-year mortality in patients undergoing percutaneous coronary interventions |
| Q59068702 | Implications of diagenesis for the isotopic analysis of Upper Miocene large mammalian herbivore tooth enamel from Chad |
| Q44406527 | Influence of Class I interferons on performance of vascular cells on stent material in vitro |
| Q40410810 | Intravascular ultrasonic assessment of stent diameters derived from manufacturer's compliance charts |
| Q83297062 | Intravascular ultrasonic differences between aorto-ostial and shaft narrowing in saphenous veins used as aortocoronary bypass grafts |
| Q51082218 | Intravascular ultrasound assessment of drug-eluting stent expansion. |
| Q80020261 | Intravascular ultrasound assessment of fibrous cap remnants after coronary plaque rupture |
| Q45253566 | Intravascular ultrasound assessment of lesions with target vessel failure after sirolimus-eluting stent implantation |
| Q79279183 | Intravascular ultrasound assessment of ulcerated ruptured plaques: a comparison of culprit and nonculprit lesions of patients with acute coronary syndromes and lesions in patients without acute coronary syndromes |
| Q80960386 | Intravascular ultrasound study of patterns of calcium in ruptured coronary plaques |
| Q73727652 | Long-term follow-up of patients after gamma intracoronary brachytherapy failure (from GAMMA-I, GAMMA-II, and SCRIPPS-III) |
| Q45240001 | Low hematocrit predicts contrast-induced nephropathy after percutaneous coronary interventions |
| Q51641037 | Luminal narrowing due to intramural hematoma shift from left anterior descending coronary artery to left circumflex artery. |
| Q28191931 | Meta-analysis of randomized and registry comparisons of ticlopidine with clopidogrel after stenting |
| Q50927625 | Nonrandomized comparison of coronary stenting under intravascular ultrasound guidance of direct stenting without predilation versus conventional predilation with a semi-compliant balloon versus predilation with a new scoring balloon. |
| Q45158732 | Nonuniform strut distribution correlates with more neointimal hyperplasia after sirolimus-eluting stent implantation |
| Q51150191 | Outcome after acute incomplete sirolimus-eluting stent apposition as assessed by serial intravascular ultrasound. |
| Q36282753 | Percutaneous recanalization of chronically occluded coronary arteries: a consensus document: part I. |
| Q36288750 | Percutaneous recanalization of chronically occluded coronary arteries: a consensus document: part II. |
| Q36254967 | Percutaneous recanalization of chronically occluded coronary arteries: procedural techniques, devices, and results |
| Q34169161 | Prediction of long-term mortality after percutaneous coronary intervention in older adults: results from the National Cardiovascular Data Registry |
| Q80193954 | Prognostic significance of cerebrovascular and peripheral arterial disease in patients having percutaneous coronary interventions |
| Q59068663 | Reply to the comment on “Implications of diagenesis for the isotopic analysis of Upper Miocene large mammalian herbivore tooth enamel from Chad” by L. Jacques, N. Ogle, I. Moussa, R. Kalin, P. Vignaud, M. Brunet and H. Bocherens [Palaeogeography, |
| Q46834201 | Short- and long-term outcomes after stent-assisted percutaneous treatment of saphenous vein grafts in the drug-eluting stent era. |
| Q46420633 | Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: an intravascular ultrasound study |
| Q40321991 | The fate of patients with clinical recurrence after sirolimus-eluting stent implantation (a two-year follow-up analysis from the SIRIUS trial). |
| Q46911870 | Treatment of restenotic drug-eluting stents: an intravascular ultrasound analysis. |
| Q99709900 | Trends and Outcomes of Restenosis After Coronary Stent Implantation in the United States |
| Q31151434 | Trends in U.S. Cardiovascular Care: 2016 Report From 4 ACC National Cardiovascular Data Registries |
| Q78772918 | Usefulness of atrial fibrillation as a marker of outcome after percutaneous coronary intervention |
| Q35885937 | Vascular complications associated with arteriotomy closure devices in patients undergoing percutaneous coronary procedures: a meta-analysis |
| Q80845993 | Vascular remodeling and plaque composition between focal and diffuse coronary lesions assessed by intravascular ultrasound |
| Q51098019 | Volumetric intravascular ultrasound assessment of neointimal hyperplasia and nonuniform stent strut distribution in sirolimus-eluting stent restenosis. |
| Q28252529 | 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventi |
Search more.